Similar results were found in a study of HCC treated with stereotactic body radiation therapy (SBRT), with reductions in CD3+, CD8+, CD4+ T cells and NK cells at 10 days after SBRT treatment (33). The gene discussed is CD4; the disease is hepatocellular carcinoma.